Ocular Therapeutix (OCUL) Revenue (2013 - 2026)
Ocular Therapeutix (OCUL) revenue from Jun 30, 2013 to Mar 31, 2026. The TTM Ocular Therapeutix (OCUL) revenue is $52M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Ocular Therapeutix (OCUL) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -12.76% |
| 3 Years TTM | +0.23% |
| 5 Years TTM | +18.64% |
| 10 Years TTM | +40.07% |
| All Time TTM | +66.52% |
Annual Revenue change of Ocular Therapeutix (OCUL)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $11M | -79.23% |
| 2025 | $52M | -18.47% |
| 2024 | $64M | +9.03% |
| 2023 | $58M | +13.50% |
| 2022 | $51M | +18.31% |
| 2021 | $44M | +150.11% |
| 2020 | $17M | +311.35% |
| 2019 | $4.23M | +112.56% |
| 2018 | $1.99M | +3.65% |
| 2017 | $1.92M | +1.59% |
| 2016 | $1.89M | +8.00% |
| 2015 | $1.75M | +127.27% |
| 2014 | $770K | +7600.00% |
| 2013 | $10K | N/A |
| 2012 | $10K | N/A |
Comparison Ocular Therapeutix (OCUL) five years revenue CAGR with competitors
Ocular Therapeutix (OCUL) five years revenue CAGR is 18.64%.